K, M., H, Y., H, W., & N, U. (2026). Utilization of Healthy Volunteers in Oncology Drug Development in Japan: A 10-Year Analysis of Approved Anticancer Agents (2014-2024). Clinical and translational science, 19(6), e70626. https://doi.org/10.1111/cts.70626
Chicago Style (17th ed.) CitationK, Morihisa, Yoshitsugu H, Wakuda H, and Uemura N. "Utilization of Healthy Volunteers in Oncology Drug Development in Japan: A 10-Year Analysis of Approved Anticancer Agents (2014-2024)." Clinical and Translational Science 19, no. 6 (2026): e70626. https://doi.org/10.1111/cts.70626.
MLA (9th ed.) CitationK, Morihisa, et al. "Utilization of Healthy Volunteers in Oncology Drug Development in Japan: A 10-Year Analysis of Approved Anticancer Agents (2014-2024)." Clinical and Translational Science, vol. 19, no. 6, 2026, p. e70626, https://doi.org/10.1111/cts.70626.